Skip to main content
Fig. 8 | Cancer Nanotechnology

Fig. 8

From: Emodin-loaded polymer-lipid hybrid nanoparticles enhance the sensitivity of breast cancer to doxorubicin by inhibiting epithelial–mesenchymal transition

Fig. 8

E-PLNs combined with DOX inhibited EMT marker protein expression and cell invasion. A, B After MCF-7/ADR cells treated with DOX, DOX + EMO, DOX + E-PLNs for 48 h, the expression of E-cadherin, N-cadherin and Vimentin were detected by Western blotting analysis. C, D The invasion activity of MCF-7/ADR cells after incubation with DOX, DOX + EMO, DOX + E-PLNs for 24 h. N = 3, **p < 0.01, ***p < 0.001 compared with DOX group

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us